Regulation of Myelopoiesis by CD137L Signaling

REFERENCES

• Cheung YY, Kim SY, Yiu WH, Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Inves 2007;117(3):784–793.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim HJ, Park K, Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease. Blood 2007;110(2):776–782.
   PubMed Web of Science ®Google Scholar
• Hakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens 2007;70(3):179–189.
   PubMedGoogle Scholar
• Oduro KA, Liu F, Tan Q, Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells. Blood 2012;120(11):2203–2213.
   PubMed Web of Science ®Google Scholar
• Brown G, Hughes PJ, Michell RH, The sequential determination model of hematopoiesis. Trends Immunol 2007;28(10):442–448.
   PubMed Web of Science ®Google Scholar
• Geissmann F, Manz MG, Jung S, Development of monocytes, macrophages, and dendritic cells. Science 2010;327(5966):656–661.
   PubMed Web of Science ®Google Scholar
• Monu NR, Frey AB. Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship. Immunol Invest 2012;41(6–7):595–613.
   PubMed Web of Science ®Google Scholar
• Seeling M, Hillenhoff U, David JP, Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci USA 2013;110(26):10729–10734.
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Wandycz AM, Akashi K, The aging of hematopoietic stem cells. Nat Med 1996;2(9):1011–1016.
   PubMed Web of Science ®Google Scholar
• Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007;211(2):144–156.
   PubMed Web of Science ®Google Scholar
• King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 2011;11(10):685–692.
   PubMed Web of Science ®Google Scholar
• Hirai H, Zhang P, Dayaram T, C/EBPbeta is required for ‘emergency’ granulopoiesis. Nat Immunol 2006;7(7):732–739.
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Zhang L, Snow JW, STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 2006;108(12):3682–3690.
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine 2008;42(3):277–288.
   PubMed Web of Science ®Google Scholar
• Boettcher S, Ziegler P, Schmid MA, Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J Immunol 2012;188(12):5824–5828.
   PubMed Web of Science ®Google Scholar
• Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine 2012;57(1):1–8.
   PubMed Web of Science ®Google Scholar
• Rieber N, Brand A, Hector A, Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013;190(3):1276–1284.
   PubMed Web of Science ®Google Scholar
• Scumpia PO, Kelly-Scumpia KM, Delano MJ, Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol 2010;184(5):2247–2251.
   PubMed Web of Science ®Google Scholar
• MacNamara KC, Oduro K, Martin O, Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-gamma signaling. J Immunol 2011;186(2):1032–1043.
   PubMed Web of Science ®Google Scholar
• de Bruin AM, Libregts SF, Valkhof M, IFNgamma induces monopoiesis and inhibits neutrophil development during inflammation. Blood 2012;119(6):1543–1554.
   PubMed Web of Science ®Google Scholar
• Deonarain R, Verma A, Porter AC, Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A 2003;100(23):13453–13458.
   PubMed Web of Science ®Google Scholar
• Pritz T, Landgraf-Rauf K, Herndler-Brandstetter D, Bone marrow T cells from the femur are similar to iliac crest derived cells in old age and represent a useful tool for studying the aged immune system. Immunity Ageing 2013;10(1):17.
   PubMedGoogle Scholar
• Kaufman CL, Colson YL, Wren SM, Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994;84(8):2436–2446.
   PubMed Web of Science ®Google Scholar
• Schneider E, Salaun V, Ben Amor A, Dy M. Hematopoietic changes induced by a single injection of anti-CD3 monoclonal antibody into normal mice. Stem Cells 1997;15(2):154–160.
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Benjamin A, Costa ES, Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood 2005;105(4):1484–1491.
   PubMed Web of Science ®Google Scholar
• Price PW, Cerny J. Characterization of CD4+ T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR Vbeta repertoire. Eur J Immunol 1999;29(3):1051–1056.
   PubMed Web of Science ®Google Scholar
• Di RF, Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol 2005;26(7):360–366.
   PubMed Web of Science ®Google Scholar
• Herndler-Brandstetter D, Landgraf K, Jenewein B, Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. J Immunol 2011;186(12):6965–6971.
   PubMed Web of Science ®Google Scholar
• Kelso A, Owens T. Production of two hemopoietic growth factors is differentially regulated in single T lymphocytes activated with an anti-T cell receptor antibody. J Immunol 1988;140(4):1159–1167.
   PubMed Web of Science ®Google Scholar
• Lee JH, Wang C, Kim CH. FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells. J Immunol 2009;183(10):6377–6386.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9(3):162–174.
   PubMed Web of Science ®Google Scholar
• Eissner G, Kolch W, Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 2004;15(5):353–366.
   PubMed Web of Science ®Google Scholar
• Pollok KE, Kim YJ, Hurtado J, 4–1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994;24(2):367–374.
   PubMed Web of Science ®Google Scholar
• Schwarz H, Valbracht J, Tuckwell J, ILA, the human 4–1BB homologue, is inducible in lymphoid and other cell lineages. Blood 1995;85(4):1043–1052.
   PubMed Web of Science ®Google Scholar
• Ho WT, Pang WL, Chong SM, Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression. Canc Res 2013;73(2):652–661.
   PubMed Web of Science ®Google Scholar
• Shao Z, Schwarz H. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J Leukoc Biol 2011;89(1):21–29.
   PubMed Web of Science ®Google Scholar
• Thum E, Shao Z, Schwarz H. CD137, implications in immunity and potential for therapy. Front Biosci 2009;14:4173–4188.
   PubMed Web of Science ®Google Scholar
• Wang S, Lv J, Wang P, Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity. Cancer Immunol Immunother 2011;61(4):489–495.
   PubMed Web of Science ®Google Scholar
• Lee SW, Croft M. 4–1BB as a therapeutic target for human disease. Adv Exp Med Biol 2009;647:120–129.
   PubMed Web of Science ®Google Scholar
• Wang C, Lin GH, McPherson AJ, Watts TH. Immune regulation by 4–1BB and 4–1BBL: complexities and challenges. Immunol Rev 2009;229(1):192–215.
   PubMedGoogle Scholar
• Saito K, Ohara N, Hotokezaka H, Infection-induced up-regulation of the costimulatory molecule 4–1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J Biol Chem 2004;279(14):13555–13563.
   PubMed Web of Science ®Google Scholar
• Lee SW, Park Y, So T, Identification of regulatory functions for 4–1BB and 4–1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol 2008;9(8):917–926.
   PubMed Web of Science ®Google Scholar
• Jiang D, Chen Y, Schwarz H. CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages. J Immunol 2008;181(6):3923–3932.
   PubMed Web of Science ®Google Scholar
• Jiang D, Yue PS, Drenkard D, Schwarz H. Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling. Stem Cells 2008;26(9):2372–2381.
   PubMed Web of Science ®Google Scholar
• Jiang D, Schwarz H. Regulation of granulocyte and macrophage populations of murine bone marrow cells by G-CSF and CD137 protein. PLoS One 2010;5(12):e15565.
   Web of Science ®Google Scholar
• Tang Q, Jiang D, Alonso S, CD137 ligand signaling enhances myelopoiesis during infections. Eur J Immunol 2013;43(6):1555–1567.
   PubMed Web of Science ®Google Scholar
• Lee SC, Ju SA, Pack HN, 4–1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect Immun 2005;73(8):5144–5151.
   PubMed Web of Science ®Google Scholar
• Lee SC, Ju SA, Sung BH, Stimulation of the molecule 4–1BB enhances host defense against Listeria monocytogenes infection in mice by inducing rapid infiltration and activation of neutrophils and monocytes. Infect Imm 2009;77(5):2168–2176.
   PubMed Web of Science ®Google Scholar
• Martinez Gomez JM, Koh VH, Yan B, Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection. Immunobiology 2014;219(1):78–86.
   PubMed Web of Science ®Google Scholar
• Tang Q, Koh LK, Jiang D, Schwarz H. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging. Aging 2013;5(9):643–652.
   PubMedGoogle Scholar
• Wang JW, Geiger H, Rudolph KL. Immunoaging induced by hematopoietic stem cell aging. Cur Opin Imm 2011;23(4):532–536.
   PubMed Web of Science ®Google Scholar
• Shin HH, Lee EA, Kim SJ, A signal through 4–1BB ligand inhibits receptor for activation of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production. FEBS Lett 2006;580(6):1601–1606.
   PubMed Web of Science ®Google Scholar
• Shin HH, Lee JE, Lee EA, Enhanced osteoclastogenesis in 4–1BB-deficient mice caused by reduced interleukin-10. J Bone Miner Res 2006;21(12):1907–1912.
   PubMed Web of Science ®Google Scholar
• Yang J, Park OJ, Lee YJ, The 4–1BB ligand and 4–1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Eur J Immunol 2008;38(6):1598–1609.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392(6673):245–252.
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106(3):255–258.
   PubMed Web of Science ®Google Scholar
• Diehl L, van Mierlo GJ, den Boer AT, In vivo triggering through 4–1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J Immunol 2002;168(8):3755–3762.
   PubMed Web of Science ®Google Scholar
• Laderach D, Wesa A, Galy A. 4–1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell Immunol 2003;226(1):37–44.
   PubMed Web of Science ®Google Scholar
• Lee PK, Chang CJ, Lin CM. Lipopolysaccharide preferentially induces 4–1BB ligand expression on human monocyte-derived dendritic cells. Immunol Lett 2003;90(2–3):215–221.
   PubMed Web of Science ®Google Scholar
• Lippert U, Zachmann K, Ferrari DM, CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur J Immunol 2008;38(4):1024–1032.
   PubMed Web of Science ®Google Scholar
• Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev 1996;153:47–83.
   PubMed Web of Science ®Google Scholar
• Ju S, Ge Y, Qiu H, A novel approach to induce human DCs from monocytes by triggering 4–1BBL reverse signaling. Int Immunol 2009;21(10):1135–1144.
   PubMed Web of Science ®Google Scholar
• Kwajah MMS, Schwarz H. CD137 ligand signaling induces human monocyte to dendritic cell differentiation. Eur J Immunol 2010;40(7):1938–1949.
   PubMed Web of Science ®Google Scholar
• Harfuddin Z, Sim ACN, MacAry PA. Schwarz H. CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses. Oncoimmunol 2013; 1;2(11):e26859.
   Google Scholar
• Jonuleit H, Kuhn U, Muller G, Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27(12):3135–3142.
   PubMed Web of Science ®Google Scholar
• Kwajah MMS, Mustafa N, Holme AL, Biphasic activity of CD137 ligand-stimulated monocytes on T cell apoptosis and proliferation. J Leuk Biol 2011;89(5):707–720.
   PubMed Web of Science ®Google Scholar
• Michel J, Pauly S, Langstein J, CD137-induced apoptosis is independent of CD95. Immunology 1999;98(1):42–46.
   PubMed Web of Science ®Google Scholar
• Schwarz H, Blanco FJ, von KJ, ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 1996;87(7):2839–2845.
   PubMed Web of Science ®Google Scholar
• Bahl K, Kim SK, Calcagno C, IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 2006;176(7):4284–4295.
   PubMed Web of Science ®Google Scholar
• Jiang J, Lau LL, Shen H. Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J Immunol 2003;171(8):4352–4358.
   PubMed Web of Science ®Google Scholar
• McNally JM, Zarozinski CC, Lin MY, Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol 2001;75(13):5965–5976.
   PubMed Web of Science ®Google Scholar
• Tang Q, Jiang D, Shao Z, Species difference of CD137 ligand signaling in human and murine monocytes. PLoS One 2011;6(1):e16129.
   Web of Science ®Google Scholar
• Zhao S, Zhang H, Xing Y, Natkunam Y. CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications. Am J Surg Pathol 2013;37(2):250–258.
   PubMed Web of Science ®Google Scholar
• Baessler T, Charton JE, Schmiedel BJ, CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells. Blood 2010;115(15):3058–3069.
   PubMed Web of Science ®Google Scholar
• Cheng K, Cheng Wong S, Ching Linn Y, CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells. Br J Haematol 2014;165(1):134–144.
   PubMed Web of Science ®Google Scholar
• Houtenbos I, Westers TM, Dijkhuis A, Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4–1BB targeting. Clin Cancer Res 2007;13(1):307–315.
   PubMed Web of Science ®Google Scholar
• Vire B, de Walque S, Restouin A, Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4–1BBL/4–1BB immunomodulatory functions. PloS One 2009;4(9):e7085.
   Web of Science ®Google Scholar
• Salih HR, Nuessler V, Denzlinger C, Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome. Leuk Lymph 2004;45(2):301–308.
   PubMed Web of Science ®Google Scholar
• Sollner L, Shaqireen DOK, Wu JT, Schwarz H. Signal transduction mechanisms of CD137 ligand in human monocytes. Cell Signal 2007;19(9):1899–1908.
   PubMed Web of Science ®Google Scholar
• Kim DK, Lee SC, Lee HW. CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: involvement of mTOR/p70S6 kinase and Akt. Eur J Immunol 2009;39(9):2617–2628.
   PubMed Web of Science ®Google Scholar
• Watts AD, Hunt NH, Wanigasekara Y, A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’. EMBO J 1999;18(8):2119–2126.
   PubMed Web of Science ®Google Scholar
• Kang YJ, Kim SO, Shimada S, Cell surface 4–1BBL mediates sequential signaling pathways ‘downstream’ of TLR and is required for sustained TNF production in macrophages. Nat Immunol 2007;8(6):601–609.
   PubMed Web of Science ®Google Scholar
• Ma J, Bang BR, Lu J, The TNF family member 4–1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation. Sci Signal 2013;6(295):ra87.
   PubMed Web of Science ®Google Scholar
• Bae JS, Choi JK, Moon JH, Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells. Cell Signal 2012;24(12):2227–2236.
   PubMed Web of Science ®Google Scholar
• Moh MC, Lorenzini PA, Gullo C, Schwarz H. Tumor necrosis factor receptor 1 associates with CD137 ligand and mediates its reverse signaling. FASEB J 2013;27(8):2957–2966.
   PubMed Web of Science ®Google Scholar